• MK 0893: Allosteric Control of GCGR Signaling

  2026-09-21

  MK 0893 is a competitive reversible glucagon receptor antagonist that connects allosteric receptor structure with functional cAMP assays and translational metabolic models. This guide explains how its binding geometry can improve assay design, selectivity analysis, and interpretation in type 2 diabetes research.

• Puromycin Aminonucleoside: Smarter Renal Models

  2026-09-20

  Puromycin aminonucleoside is a powerful tool for connecting podocyte damage with proteinuria and glomerular pathology. This evidence-centered guide explains how to design interpretable renal injury assays, distinguish cellular toxicity from disease-like remodeling, and apply insights from a mechanistic cancer study without overextending the evidence.

• Baricitinib (LY3009104): JAK1/2 Research Guide

  2026-09-19

  Baricitinib, also called LY3009104, is an ATP-competitive JAK1/JAK2 inhibitor for research on cytokine signaling and inflammatory disease models. Its reported low-nanomolar activity supports studies of STAT3 phosphorylation, IL-6 signaling, IL-23 signaling, and preclinical arthritis models, but the cited PSC study does not establish a therapeutic effect in primary sclerosing cholangitis.

• β-NMN and Diabetic Myocardial Fibrosis

  2026-09-18

  A 2026 mouse study links NMN-mediated protection against diabetic myocardial fibrosis with increased SIRT3 activity, reduced GSK3β acetylation, and lower Smad3 phosphorylation. The findings provide a mechanistic framework for studying NAD+-dependent metabolic regulation in cardiac remodeling, while remaining preliminary because the evidence is pharmacological and preclinical.

• Electrical Stimulation Enhances Magnetic Nanoparticle Uptake

  2026-09-18

  The reference study shows that alternating-current electrical stimulation increases magnetic nanoparticle endocytosis in cancer cells, primarily through macropinocytosis associated with reduced F-actin and elevated intracellular Ca2+. The approach improves both magnetic hyperthermia and MRI-related readouts and remains effective across several cancer cell types, particle sizes, and nanoparticle compositions.

• AMD-070 hydrochloride: CXCR4 Assay Workflows

  2026-09-17

  Build more interpretable CXCR4 experiments with AMD-070 hydrochloride, from receptor-signaling and migration assays to exploratory HIV entry inhibition models. This guide combines product-handling guidance with a protoplast-based assay concept that helps separate membrane effects, osmotic artifacts, and pathway-specific biology.

• Sulfaphenazole Restores Perfusion in Skin Injury

  2026-09-17

  Turner and colleagues show that sulfaphenazole limits pressure- and thermal-injury severity in ischemia–reperfusion models by rapidly restoring local tissue perfusion. The study connects vascular protection with lower hypoxia, inflammation, fibrosis, and improved wound repair, while also providing a useful framework for evaluating therapies that target post-ischemic no-reflow.

• Removing Pollen Interference in Bioaerosol Spectra

  2026-09-16

  Zhang et al. developed a fluorescence-data workflow that reduces pollen interference when classifying hazardous bioaerosols. Combining excitation–emission matrix spectroscopy, spectral transformations, and random forest modeling improved reported classification accuracy to 89.24%, supporting more reliable rapid screening.

• In Situ Electroporation for Nucleic Acid Screening

  2026-09-16

  The reference study combines localized in situ electroporation with electric cell-substrate impedance sensing to deliver plasmid DNA, mRNA, siRNA, and aptamers directly into adherent mammalian cells while monitoring membrane perturbation and recovery. This integrated workflow supports both gain-of-function and loss-of-function experiments, linking intracellular nucleic acid delivery to early phenotypic responses without requiring detachment of the cells.

• Chlorpromazine HCl in Endocytosis Research

  2026-09-15

  Chlorpromazine HCl is more than a dopamine receptor antagonist: it can serve as a mechanistic perturbation tool for testing clathrin-dependent entry in Drosophila S2 cells. This guide connects infection assays with neuropharmacology workflows while emphasizing dose control, viability checks, and orthogonal pathway validation.

• Sulfo-NHS-Biotin for Host-Pathogen Assays

  2026-09-15

  Sulfo-NHS-Biotin enables controlled surface-protein capture, affinity enrichment, and immunoprecipitation workflows in macrophage infection studies. Its membrane-impermeant chemistry complements the iScience study of GSK3-dependent control of intracellular Mycobacterium tuberculosis by adding a practical way to monitor host-cell surface remodeling.

• Sulfo-NHS-Biotin for Protein Labeling

  2026-09-14

  Learn how Sulfo-NHS-Biotin enables aqueous, amine-selective labeling for cell-surface analysis, affinity capture, and immunoprecipitation workflows. A practical protocol connects this chemistry with the avidin/biotin surface-engineering strategy reported for PEGylated PLGA microspheres.

• Puromycin Aminonucleoside: Podocyte Injury Model

  2026-09-14

  Puromycin aminonucleoside is the aminonucleoside moiety of puromycin and a widely used experimental nephrotoxic agent. It produces proteinuria, podocyte structural injury, and rat glomerular lesions resembling focal segmental glomerulosclerosis, while product-specific cytotoxicity and solubility data support assay planning.

• Protease Inhibitor Cocktail for DFCP1–ATGL Assays

  2026-09-13

  Protect DFCP1–ATGL complexes and labile lipid-droplet proteins during cell or tissue extraction with a broad-spectrum, water-soluble formulation. This workflow explains when EDTA helps, when it must be removed, and how to connect biochemical recovery with starvation-induced lipolysis assays.

• Sulfo-NHS-Biotin for GSK3-Mtb Host Studies

  2026-09-12

  Sulfo-NHS-Biotin enables membrane-impermeant cell surface protein labeling, making it useful for separating extracellular host responses from intracellular signaling during Mycobacterium tuberculosis research. This guide translates GSK3 perturbation findings into practical surface-capture, affinity enrichment, and troubleshooting workflows without treating biotinylation as a substitute for functional infection assays.

8074 records 1/539 page Next 12345 下5页 Last page